AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34002642 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligament reconstruction with tendon interposition
Number of subjects: 18
Study 34232582 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX) 30-70 mg/d (mean 59.1 ± 14.8 mg/d)
Number of subjects: 38
Study 34232582 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX)
Number of subjects: 38
Study 34232582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 33354956 — intervention group
Group type: EXPERIMENTAL
Intervention: Qianlie Beixi Capsules combined with Magnetic Resonance Electromagnetic Therapy (MREM)
Number of subjects: 124
Study 33354956 — intervention group
Group type: COMPARATOR
Intervention: Qianlie Beixi Capsules (QBC)
Number of subjects: 124
Study 34791789 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cyclosporine cream delivered by fractional CO2 laser
Number of subjects: 22
Study 34791789 — intervention group
Group type: COMPARATOR
Intervention: Topical clobetasol cream
Number of subjects: 22
Study 33546304 — intervention group
Group type: EXPERIMENTAL
Intervention: HESPER Web
Number of subjects: 308
Study 33546304 — intervention group
Group type: COMPARATOR
Intervention: Self-selected study sample
Number of subjects: 308
Study 36106832 — intervention group
Group type: EXPERIMENTAL
Intervention: Menstrual Cycle (MC) phases
Number of subjects: 40
Study 36106832 — intervention group
Group type: COMPARATOR
Intervention: Oral Contraceptive (OC) users
Number of subjects: 40
Study 36644237 — intervention group
Group type: EXPERIMENTAL
Intervention: Efruxifermin 50 mg once-weekly for 16 weeks
Number of subjects: 30
Study 36644237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33821769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-oriented threat present, other-oriented threat present, efficacy present
Number of subjects: 324
Study 33821769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-oriented threat absent, other-oriented threat present, efficacy present
Number of subjects: 324
Study 33821769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-oriented threat present, other-oriented threat absent, efficacy present
Number of subjects: 324
Study 33821769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-oriented threat present, other-oriented threat present, efficacy absent
Number of subjects: 324
Study 33821769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-oriented threat absent, other-oriented threat absent, efficacy present
Number of subjects: 324
Study 33821769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-oriented threat absent, other-oriented threat present, efficacy absent
Number of subjects: 324
Study 33821769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-oriented threat present, other-oriented threat absent, efficacy absent
Number of subjects: 324
Study 33821769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-oriented threat absent, other-oriented threat absent, efficacy absent
Number of subjects: 324
Study 36129617 — intervention group
Group type: EXPERIMENTAL
Intervention: Online transitional care communication skills training (OTCCST)
Number of subjects: 38
Study 36129617 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of OTCCST and transitional care (TC)
Number of subjects: 38
Study 36129617 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 33407590 — intervention group
Group type: EXPERIMENTAL
Intervention: ETA+MTX
Number of subjects: 68
Study 33407590 — intervention group
Group type: COMPARATOR
Intervention: Placebo+MTX
Number of subjects: 68
Study 35562596 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning combined with traditional radiomics methods
Number of subjects: 276
Study 35562596 — intervention group
Group type: COMPARATOR
Intervention: Radiologists' diagnostic performance
Number of subjects: 276
Study 34360146 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration (V)
Number of subjects: 31
Study 34360146 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 31
Study 34360146 — intervention group
Group type: COMPARATOR
Intervention: No vibration (NV)
Number of subjects: 31
Study 35791938 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 100
Study 34776925 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance Intervention (DI)
Number of subjects: 68
Study 33407189 — intervention group
Group type: EXPERIMENTAL
Intervention: Reablement training program 'Stay Active at Home' for homecare staff
Number of subjects: 154
Study 32587397 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA + PUI
Number of subjects: 80
Study 32587397 — intervention group
Group type: EXPERIMENTAL
Intervention: QMiX + PUI
Number of subjects: 80
Study 32587397 — intervention group
Group type: COMPARATOR
Intervention: EDTA + CI
Number of subjects: 80
Study 32587397 — intervention group
Group type: COMPARATOR
Intervention: QMiX + CI
Number of subjects: 80
Study 35810980 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental Variables (IV) methods
Number of subjects: 0
Study 35810980 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 0
Study 35810980 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider preference
Number of subjects: 0
Study 35810980 — intervention group
Group type: EXPERIMENTAL
Intervention: IV analysis
Number of subjects: 0
Study 35810980 — intervention group
Group type: EXPERIMENTAL
Intervention: IV methods
Number of subjects: 0
Study 33333440 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Internalized Stigma Program (PAREI)
Number of subjects: 54
Study 33333440 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 32881765 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA (2 g) administered prior to hospital arrival, less than 2 hours postinjury.
Number of subjects: 287
Study 32881765 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA (2 g) administered less than 45 minutes postinjury.
Number of subjects: 287
Study 32881765 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered prior to hospital arrival, less than 2 hours postinjury.
Number of subjects: 287
Study 34117788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu AG06466
Number of subjects: 49
Study 34117788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 32840126 — intervention group
Group type: EXPERIMENTAL
Intervention: Reishi & Privet Formula (RPF) 3.36 g/day for 6 weeks
Number of subjects: 82
Study 32840126 — intervention group
Group type: EXPERIMENTAL
Intervention: Reishi & Privet Formula (RPF)
Number of subjects: 82
Study 32840126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 36289483 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated-experience format (interactive simulation)
Number of subjects: 600
Study 36289483 — intervention group
Group type: COMPARATOR
Intervention: Descriptive format (fact box)
Number of subjects: 600
Study 33330913 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum/egg supplementation (BC/egg)
Number of subjects: 277
Study 33330913 — intervention group
Group type: COMPARATOR
Intervention: Corn/soy flour (control)
Number of subjects: 277
Study 36369513 — intervention group
Group type: EXPERIMENTAL
Intervention: SWiM-C
Number of subjects: 388
Study 36369513 — intervention group
Group type: COMPARATOR
Intervention: Standard advice
Number of subjects: 388
Study 32567789 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended early intervention (EI) for psychosis
Number of subjects: 220
Study 32567789 — intervention group
Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 220
Study 32567789 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended EI (satisfied group)
Number of subjects: 220
Study 32380983 — intervention group
Group type: EXPERIMENTAL
Intervention: Computable phenotype for ADHF
Number of subjects: 938
Study 32380983 — intervention group
Group type: COMPARATOR
Intervention: ICD-9 codes for Acute Heart Failure
Number of subjects: 938
Study 32380983 — intervention group
Group type: COMPARATOR
Intervention: All Heart Failure codes (ICD-9)
Number of subjects: 938
Study 34538272 — intervention group
Group type: EXPERIMENTAL
Intervention: SELFIE (digital guided self-help intervention administered through a smartphone-based app, blended with three training sessions over a 6-week period)
Number of subjects: 0
Study 34538272 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 33200214 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTsmart intervention (guided smartphone-delivered Acceptance and Commitment Therapy) for 8 weeks
Number of subjects: 34
Study 33200214 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTsmart intervention
Number of subjects: 34
Study 32956694 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg estetrol / 3 mg drospirenone (E4/DRSP)
Number of subjects: 101
Study 32956694 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mcg ethinylestradiol / 150 mcg levonorgestrel (EE/LNG)
Number of subjects: 101
Study 32956694 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mcg ethinylestradiol / 3 mg drospirenone (EE/DRSP)
Number of subjects: 101
Study 34143278 — intervention group
Group type: EXPERIMENTAL
Intervention: CORDIS (body-focused group therapy)
Number of subjects: 53
Study 34143278 — intervention group
Group type: COMPARATOR
Intervention: Guided self-help group (SHG)
Number of subjects: 53
Study 34889742 — intervention group
Group type: EXPERIMENTAL
Intervention: MumMoodBooster (MMB)
Number of subjects: 116
Study 34889742 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face Cognitive Behavioral Therapy (FTF-CBT)
Number of subjects: 116
Study 34889742 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 116
Study 33441095 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard balloon kyphoplasty (BKP)
Number of subjects: 14
Study 33441095 — intervention group
Group type: EXPERIMENTAL
Intervention: Tektona® (TEK)
Number of subjects: 14
Study 33939383 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise with dietary modification
Number of subjects: 35
Study 33939383 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise with dietary modification
Number of subjects: 35
Study 32446591 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulator model surgery (AMS) with an intermediate occlusal splint made of acrylic resin
Number of subjects: 30
Study 32446591 — intervention group
Group type: COMPARATOR
Intervention: Virtual surgical planning (VSP) with the same intermediate splint fabricated using rapid prototyping technology
Number of subjects: 30
Study 32446591 — intervention group
Group type: COMPARATOR
Intervention: Both AMS and VSP
Number of subjects: 30
Study 35954786 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional development program of Project GIFT
Number of subjects: 2031
Study 35954786 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2031
Study 33484335 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate meal (HCHO)
Number of subjects: 15
Study 33484335 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-macronutrient meal (MM)
Number of subjects: 15
Study 32289193 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-being therapy (WBT)
Number of subjects: 64
Study 35316669 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood stabilizer combined with antidepressant
Number of subjects: 104
Study 35316669 — intervention group
Group type: COMPARATOR
Intervention: Mood stabilizer
Number of subjects: 104
Study 33186665 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent reviewer assessment of any RHD
Number of subjects: 784
Study 33186665 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent reviewer assessment of definite RHD
Number of subjects: 784
Study 33186665 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent reviewer assessment of borderline RHD
Number of subjects: 784
Study 33186665 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-rater agreement on the presence of any RHD
Number of subjects: 784
Study 33186665 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-rater agreement for specific 2012 WHF classification
Number of subjects: 784
Study 34857667 — intervention group
Group type: EXPERIMENTAL
Intervention: Skyflow device
Number of subjects: 192
Study 34857667 — intervention group
Group type: COMPARATOR
Intervention: Solitaire FR stent
Number of subjects: 192
Study 32527153 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF treatment
Number of subjects: 343
Study 32527153 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients receiving anti-TNF for IBD for other conditions)
Number of subjects: 343
Study 35763494 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D endoscopic video
Number of subjects: 62
Study 35763494 — intervention group
Group type: COMPARATOR
Intervention: 2D endoscopic video
Number of subjects: 62
Study 35763494 — intervention group
Group type: COMPARATOR
Intervention: Microscopic video
Number of subjects: 62
Study 35763494 — intervention group
Group type: COMPARATOR
Intervention: 2D and 3D endoscopic videos
Number of subjects: 62
Study 32507151 — intervention group
Group type: EXPERIMENTAL
Intervention: PNF contract-relax technique
Number of subjects: 30
Study 32507151 — intervention group
Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 30
Study 36099977 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ECG monitoring for 7 days at start of the study (t=0), after one (t=1) and 2 years (t=2).
Number of subjects: 1860
Study 36099977 — intervention group
Group type: COMPARATOR
Intervention: Usual diagnostic care procedures.
Number of subjects: 1860
Study 34441942 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral parenteral nutrition (PPN) with Peri‐Olimel N4‐E
Number of subjects: 158
Study 34441942 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluid therapy (FT)
Number of subjects: 158
Study 35848154 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Total Knee Arthroplasty (RA-TKA)
Number of subjects: 72
Study 35848154 — intervention group
Group type: COMPARATOR
Intervention: Conventional Manual Total Knee Arthroplasty (CM-TKA)
Number of subjects: 72
Study 33813352 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated personalized feedback intervention (PFI)
Number of subjects: 125
Study 33813352 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 125
Study 33434271 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy Journey (gamified, online learning environment with 10 modules targeting EF deficits)
Number of subjects: 39
Study 33434271 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy Journey
Number of subjects: 39
Study 33036638 — intervention group
Group type: EXPERIMENTAL
Intervention: Octyl-2-cyanoacrylate tissue adhesive alone (Group A)
Number of subjects: 32
Study 33036638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesive after continuous subcuticular suture (Group B)
Number of subjects: 32
Study 33036638 — intervention group
Group type: COMPARATOR
Intervention: Skin staples (Group C)
Number of subjects: 32
Study 33036638 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 32
Study 35029238 — intervention group
Group type: EXPERIMENTAL
Intervention: Afatinib monotherapy
Number of subjects: 0
Study 35029238 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of afatinib and HAD-B1
Number of subjects: 0
Study 34970203 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (25 mg per day) before bedtime for 28 days
Number of subjects: 0
Study 34970203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35887937 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive periodontal treatment
Number of subjects: 140
Study 35887937 — intervention group
Group type: COMPARATOR
Intervention: Community-based periodontal care
Number of subjects: 140
Study 34889293 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion therapy (3 sessions per week for 8 weeks)
Number of subjects: 40
Study 34889293 — intervention group
Group type: COMPARATOR
Intervention: Waiting group (no intervention)
Number of subjects: 40
Study 34819347 — intervention group
Group type: COMPARATOR
Intervention: Routine Manual Control (RMC)
Number of subjects: 24
Study 34819347 — intervention group
Group type: EXPERIMENTAL
Intervention: SPOCold with 2s averaging time
Number of subjects: 24
Study 34819347 — intervention group
Group type: EXPERIMENTAL
Intervention: SPOCnew with 2s averaging time
Number of subjects: 24
Study 34819347 — intervention group
Group type: EXPERIMENTAL
Intervention: SPOCold with 8s averaging time
Number of subjects: 24
Study 34819347 — intervention group
Group type: EXPERIMENTAL
Intervention: SPOCnew with 8s averaging time
Number of subjects: 24
Study 32265057 — intervention group
Group type: EXPERIMENTAL
Intervention: VB-111 and paclitaxel (therapeutic dose 80 mg/m2)
Number of subjects: 21
Study 32265057 — intervention group
Group type: EXPERIMENTAL
Intervention: VB-111 and paclitaxel (therapeutic dose)
Number of subjects: 21
Study 32265057 — intervention group
Group type: COMPARATOR
Intervention: Sub-therapeutic dose of VB-111 and paclitaxel
Number of subjects: 21
Study 33389627 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted arthroplasty (RAA)
Number of subjects: 199
Study 36237183 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut microbiome analysis in HUA patients
Number of subjects: 168
Study 36237183 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial biomarkers
Number of subjects: 168
Study 36237183 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model of microbial biomarkers and clinical factors
Number of subjects: 168
Study 34325580 — intervention group
Group type: EXPERIMENTAL
Intervention: Health orientation (psychographic framework)
Number of subjects: 1201
Study 34325580 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise behavior
Number of subjects: 1201
Study 32099975 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptococcus salivarius M18 (SsM18) given once a day for 3 months (group A)
Number of subjects: 58
Study 32099975 — intervention group
Group type: COMPARATOR
Intervention: No treatment (group B)
Number of subjects: 58
Study 35279078 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin 4000 UI subcutaneously every other day (n = 67)
Number of subjects: 134
Study 35279078 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (n = 67)
Number of subjects: 134
Study 34856961 — intervention group
Group type: EXPERIMENTAL
Intervention: Racial Discrimination (RD)
Number of subjects: 483
Study 34856961 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Discrimination (WD)
Number of subjects: 483
Study 34856961 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Interference
Number of subjects: 483
Study 34856961 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Intensity
Number of subjects: 483
Study 35758878 — intervention group
Group type: EXPERIMENTAL
Intervention: ALVAC/gp120 + MF59 vaccines
Number of subjects: 1893
Study 33940998 — intervention group
Group type: EXPERIMENTAL
Intervention: Silk suture
Number of subjects: 300
Study 33940998 — intervention group
Group type: COMPARATOR
Intervention: Cyanoacrylate bio-adhesive
Number of subjects: 300
Study 35482890 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated authenticity
Number of subjects: 4040
Study 35482890 — intervention group
Group type: COMPARATOR
Intervention: Other-rated authenticity
Number of subjects: 4040
Study 35482890 — intervention group
Group type: COMPARATOR
Intervention: Rater's own authenticity
Number of subjects: 4040
Study 35482890 — intervention group
Group type: COMPARATOR
Intervention: Meta-perceptions of authenticity
Number of subjects: 4040
Study 35734671 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg misoprostol
Number of subjects: 357
Study 35734671 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 μg misoprostol
Number of subjects: 357
Study 35734671 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 μg misoprostol
Number of subjects: 357
Study 35734671 — intervention group
Group type: COMPARATOR
Intervention: 800 μg misoprostol vs 400 μg misoprostol
Number of subjects: 357
Study 35734671 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher misoprostol dosage
Number of subjects: 357
Study 35734671 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 357
Study 33012544 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorable attitude toward organ donation
Number of subjects: 382
Study 33012544 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to donate organs
Number of subjects: 382
Study 33012544 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness
Number of subjects: 382
Study 33012544 — intervention group
Group type: EXPERIMENTAL
Intervention: Membership in Red Cross Association
Number of subjects: 382
Study 33012544 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory technologist
Number of subjects: 382
Study 33012544 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical doctor
Number of subjects: 382
Study 34862661 — intervention group
Group type: EXPERIMENTAL
Intervention: isCGM intervention group (n = 33)
Number of subjects: 64
Study 34862661 — intervention group
Group type: COMPARATOR
Intervention: SMBG control group (n = 31)
Number of subjects: 64
Study 34862661 — intervention group
Group type: EXPERIMENTAL
Intervention: isCGM intervention group
Number of subjects: 64
Study 34503644 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin hydrochloride 250 mg (test product)
Number of subjects: 48
Study 34503644 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin hydrochloride 250 mg (reference product)
Number of subjects: 48
Study 33158415 — intervention group
Group type: EXPERIMENTAL
Intervention: Fishmeal-based diet labeled with stable isotopes 15N and 13C at inclusion levels of 2% and 1%, respectively, during a 12-day feed conversion test.
Number of subjects: 2281
Study 33158415 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbon and nitrogen metabolism in the liver.
Number of subjects: 2281
Study 33158415 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcriptomic analysis of liver.
Number of subjects: 2281
Study 32660329 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental malingering condition
Number of subjects: 0
Study 32660329 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition Discrimination (RD) score
Number of subjects: 0